Michelle A Bylicky
Overview
Explore the profile of Michelle A Bylicky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
173
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aryankalayil M, Patel H, May J, Shankavaram U, Bylicky M, Martello S, et al.
Sci Rep
. 2024 Oct;
14(1):22957.
PMID: 39362942
Radiation injury, either from radiotherapy or a mass-casualty event requires a health care system that can efficiently allocate resources to patients. We conducted a comprehensive transcriptome analysis of whole blood...
2.
Martello S, Ueda Y, Bylicky M, Pinney J, Dalo J, Scott K, et al.
Radiat Res
. 2024 Aug;
202(3):489-502.
PMID: 39089691
Radiation exposure in a therapeutic setting or during a mass casualty event requires improved medical triaging, where the time to delivery and quantity of medical countermeasures are critical to survival....
3.
Bylicky M, Shankavaram U, Aryankalayil M, Chopra S, Naz S, Sowers A, et al.
Mol Cancer Ther
. 2024 Feb;
23(4):577-588.
PMID: 38359816
Treatments involving radiation and chemotherapy alone or in combination have improved patient survival and quality of life. However, cancers frequently evade these therapies due to adaptation and tumor evolution. Given...
4.
Martello S, Bylicky M, Shankavaram U, May J, Chopra S, Sproull M, et al.
Radiat Res
. 2023 Aug;
200(3):266-280.
PMID: 37527359
Whole- or partial-body exposure to ionizing radiation damages major organ systems, leading to dysfunction on both acute and chronic timescales. Radiation medical countermeasures can mitigate acute damages and may delay...
5.
Aryankalayil M, Bylicky M, Chopra S, Dalo J, Scott K, Ueda Y, et al.
Cytogenet Genome Res
. 2023 Jun;
163(3-4):103-109.
PMID: 37285811
Radiation-related normal tissue injury sustained during cancer radiotherapy or in a radiological or mass casualty nuclear incident is a major health concern. Reducing the risk and mitigating consequences of radiation...
6.
Aryankalayil M, Bylicky M, Martello S, Chopra S, Sproull M, May J, et al.
Int J Radiat Biol
. 2023 May;
99(11):1702-1715.
PMID: 37212632
Purpose: Previous research has highlighted the impact of radiation damage, with cancer patients developing acute disorders including radiation induced pneumonitis or chronic disorders including pulmonary fibrosis months after radiation therapy...
7.
Aryankalayil M, Bylicky M, Martello S, Chopra S, Sproull M, May J, et al.
Sci Rep
. 2023 Jan;
13(1):200.
PMID: 36604457
Radiation injury from medical, accidental, or intentional sources can induce acute and long-term hepatic dysregulation, fibrosis, and cancer. This long-term hepatic dysregulation decreases quality of life and may lead to...
8.
May J, Shankavaram U, Bylicky M, Chopra S, Scott K, Martello S, et al.
Sci Rep
. 2022 Jul;
12(1):12333.
PMID: 35853961
In a mass radiation exposure, the healthcare system may rely on differential expression of miRNA to determine exposure and effectively allocate resources. To this end, miRNome analysis was performed on...
9.
Buchsbaum J, Espey M, Obcemea C, Capala J, Ahmed M, Prasanna P, et al.
J Clin Oncol
. 2022 Mar;
40(17):1861-1869.
PMID: 35245101
No abstract available.
10.
Eke I, Aryankalayil M, Bylicky M, Makinde A, Liotta L, Calvert V, et al.
Sci Rep
. 2022 Mar;
12(1):3500.
PMID: 35241721
The efficacy of molecular targeted therapy depends on expression and enzymatic activity of the target molecules. As radiotherapy modulates gene expression and protein phosphorylation dependent on dose and fractionation, we...